Indmedica Home | About Indmedica | Medical Jobs | Advertise On Indmedica
Search Indmedica Web
Indmedica - India's premier medical portal

Biomedical Research

Retrospective assessment of 173 patients diagnosed with preeclampsia (including eclampsia): A study of 6 years

Author(s): Berna Erdoğmuş, Haluk Mergen, Hüseyin Ivit, Atilla Köksal

Vol. 21, No. 2 (2010-04 - 2010-06)

Berna Erdoğmuş٭, Haluk Mergen٭٭, Hüseyin Ivit٭٭٭, Atilla Köksal٭٭٭

٭ Family Physician, Nilüfer #08 Family Health Center, Bursa, Turkey
٭٭Family Physician, Nilüfer #18 Family Health Center, Bursa, Turkey
٭٭٭Department of Obstetrics and Gynecology, Atatürk Research and Training Hospital, Izmir, Turkey


Preeclampsia is a multisystemic, multiphasic, multitheoretical and preventable disorder de-teriorating both mother and child’s health. One hundred seventy three preeclampsia (in-cluding eclampsia) cases admitted to our clinic evaluated retrospectively between 1996 and 2002, in Izmir, Turkey, which is a socioeconomically challenged country. 66.5% of patients were primiparas. Mean gestational week was 35.8 ± 4.75. According to the gestational week, 60.1% were preterm (<38th week), 37.6% term (38-40th week) and 2.3% postmature (>40th week). Mean arterial pressure levels were 126±4.9 mmHg before treatment and 98.2±11.7 mmHg after treatment. An associated edema was found in 85.5% and proteinuria in 80.4% of patients. After treatment, 60.1% of patients had recovered. Caesarean section delivery incidence was 37.6%. Early diagnosis of preeclampsia is essential for the diminu-tion of perinatal mortality, especially where dominate poor socioeconomic conditions exist.

Keywords: Preeclampsia, hypertension, poor socioeconomic
Accepted February 17 2010


Preeclampsia (including eclampsia) is multisystemic, multiphasic, and multitheoretical, with an unknown ori-gin, and can develop due to inadequate follow-up during pregnancy more frequently in areas with a low socioeco-nomic status [1].

Preeclampsia could be defined as a progressive hypertension (>140/90 mmHg) occurring after the 20th week of gestation, most frequently in the last 6 weeks. It occurs in 14-20% of the primigravidas, in 5.7-7.3% of multigravi-das and in 25% of chronic hypertensives. It could be responsible for 15% of all maternal mortality during pregnancy [2]. The course of hypertension caused by pregnancy could vary from pure hypertension to preeclampsia, eclampsia, and HELLP (Hypertension, Elevated Liver Enzymes, Low Platelets) Syndrome [2]. Hypertension due to pregnancy is the most common cause of maternal and perinatal mortality and morbidity all over the world [3,4]. This situation requires early diagnosis, an appropriate approach, and urgent treatment. These pregnant women must be monitored carefully and intensively. When the fetus reaches a state in which s/he may not survive, delivery must be performed. In our study, the importance of early diagnosis of preeclampsia, determination of risk factors, training of the patient, careful and regular antenatal evaluation, and appropriate treatment for prevention and conservation of the mother and the child are emphasized.

Material and Methods

In this study, the demographic values, obstetrical histories, laboratory findings and clinical evaluations of 173 patients hospitalized and treated for a diagnosis of preeclampsia (including eclampsia) between September 1996 and May 2002 in Atatürk Research and Training Hospital in Izmir were evaluated retrospectively. Concerning the rearrangement of antihypertensive therapy, the use of α-methyl-dopa as the primary step of treatment is thought convenient to patients who had severe preeclampsia, with unresponsiveness to diet and rest therapy. During MgSO4 therapy, deep tendon reflexes and hourly urinary output were observed carefully. All patients’ information was obtained from protocol registers and patients’ files. Demographic obstetrical histories, laboratory findings and clinical parameters of all patients were entered in tables in Microsoft Office Excel Pocket Program format. The statistical significance of mean average and percentages of all enrolled patients was evaluated. Chi-square and variance analysis were performed using SPSS v9.0 Pocket Program. P<0.05 is defined as statisticcally significant. Retrospective assessment of 173 patients diagnosed with preeclampsia

The frequencies of seasonal distribution of submission to hospital were: 50 patients (28.9%) in spring, 45 (26%) in winter, 43 (24.9%) in autumn, 35 (20.2%) in summer. Mean treatment duration of patients was 5.2 ± 1.7 days. Mean age was 27 ± 5.4 years. 91 patients (52.6%) lived in rural area. 115 patients were primiparas (66.4%). Mean gestational week was 35 ± 7.5. According to gesta-tional week, 104 patients (60.1%) were preterm, 65 term (37.6%), and 4 postmature (2.3%) (Table 1). 8 patients (4.6%) had previous preeclampsia (including eclampsia) history. Mean arterial pressure was 126.49 mmHg before treatment. It was found to be 98.21 mmHg after treat-ment. Edema was present in 148 patients (85.5%) and proteinuria in 142 (80.4%). According to laboratory val-ues of pregnant women at submission, in 105 patients (60.7%) WBC, in 153 (88.4%) ALP, and in 95 (54.9%) LDH values were elevated. In 107 cases Na+ (61.8%), and in 72 (41.6%) Ca++ values were below normal. Fol-lowing therapy, 168 patients (97.1%) had recovered. Caeserean section delivery incidence was found to be 37.6% (65 patients). In our clinic, abdominal section caesarean is the preferred operation in the case of preeclampsia.

Table 1. Case Distribution According to Maturity

(Gestational Week). (Premature: <38th week, term (38-40th week) and postmature (>40th week)) Cases

Cases n Ratio (%)
Premature 104 60.1
Term 65 37.6
Postmature 4 2.3
Total 173 100.0

Table 2. Relationship between blood platelet number during the hospitalization time and prognosis (χ2: 12.313, P<0.05). (Low: platelets<140000 K/μL, normal: platelets 140000 – 440000 K/μL, high: platelets >440000 K/μL)

    Prognosis n
    Exitus Recovery  
Blood Platelet Number Low 4 44 48
  Normal 1 121 122
  High 0 3 3
Total   5 168 173

Table 3. Relationship between Gestational Week (Maturity) and Fetal Distress (χ2: 24.037, P<0.05). (Premature (<38th week), term (38-40th week) and postmature (>40th week))

    Fetal Distress
    Present Absent
Gestational Week Premature 71 33
  Term 30 35
  Postmature 3 1
Total   104 69

Table 4. Case Distribution According to Parity

  Number of patients Ratio (%)
Primipara 115 66.5
Multigravida 58 33.5
Total 173 100.0

A significant relation was found between platelet count at submission and a good prognosis (P<0.05). If the number of platelets were reduced, the prognosis was worse. Similarly, a relationship was found between platelet count at submission and incoming patient’s status (P<0.05). As the platelet count was lower, the probability of severe preeclampsia (including eclampsia) increased (Table 2) (χ2: 12.313, P<0.05). As the gestational week progressed, the probability of fetal distress was increased (Table 3) (χ2: 24.037, P<0.05). The incidence of primiparity was sig-nificantly greater than (66.5%, 115 patients) multigravidity (33.5%, 58 patients) in patients with preeclampsia (including eclampsia) (Table 4). The dwellings of 91 patients (53.9%) were rural (midtown, village, peripherals of towns and midtowns). 82 patients (46.1%) had urban localizations (town, district). Mean gestational week was 35±4.75.

Hypertensive retinopathy was encountered in 11.6% (20 patients) of cases. Retinopathy was found in 20 out of 23 (86.9%) severe preeclamptic cases. Total blood protein level and albumin levels were properly related to edema. In 51.5% of cases (69 patients), baby’s weight was found under normal ranges. In 47% of patients (63 patients), birth weight was within normal range. In our study a significant relation was established between WBC and preeclampsia-eclampsia occurrence probability at hospitallization (P<0.05). In addition, a relationship was established between reduction of platelets and worsening of prognosis (P<0.05). The incidence of preeclampsia was found to be 3.8% in December in our trial. Preeclampsia was diminished in spring and summer (in August 2.46%). In our study, incidence in February was 11.6% (20 patients) and 5.2% in August.


The incidence of hypertension induced by pregnancy is very high [2]. If the conceptional age is advanced, the incidence of chronic hypertension and superimposed preeclampsia-eclampsia is increased. When pregnancies over the age of 35 years old and under age of 20 years old were compared, the risk significantly increases for over-35 year olds [3]. Our findings were similar regarding age of parity. In the literature, the notion that in some regions the illness is found much more frequently among poor women is often derided [3].

Preeclampsia (including eclampsia) generally occurred in the 3rd trimester, especially between 30th and 36th week of gestation. In the literature, it is described that accompanying renal and hypertensive diseases are usually seen with preeclampsia, which worsen the prognosis [5,6,7]. This finding is notified as arteriolar vasospasm in 80% of cases [2,8]. It is also described that retinal edema is rare and hemorrhage and exudation are less than 2%. According to the literature, arteriolar vasoconstriction is properly related to the severity of the syndrome [2,3,9]. Our find-ings support this claim. With decreased total blood pro-tein and albumin levels, the incidence and severity of edema increases [6]. Proteinuria is the major sign of preeclampsia as described in literature [5,6]. In preeclamptic patients with proteinuria, the risk of premature delivery and perinatal mortality is significantly increased [7,10]. Waugh et al, described that there is a significant relation between mean arterial pressure and neonatal weight [11]. With increased levels of hypertension, the probability of low birth weight increases. However, we could not find any statistically supportive findings about this fact. Nevertheless, in the literature, perinatal mortality and mean blood pressure were found to be closely related [1]. As the mean blood pressure increases, the perinatal mortality increases.

Despite various therapies (α-methyl-dopa, MgSO4 e.g.), the patients in whom blood pressure couldn’t be con-trolled, especially those with a blood pressure greater than 110 mmHg, with liver enzymes levels elevated, with thrombocytopenia and pulmonary edema beginning to develop, proceeding to HELLP Syndrome, or deepening of fetal hypoxia occurring, must immediately be delivered. In mild cases, MgSO4 therapy was not the first choice of therapy. In eclampsia and severe preeclampsia, MgSO4 was the first and only choice of therapy. There was a significant correlation between our clinic’s protocol and that of the literature. Superiorities of MgSO4 therapy are described in the studies of Sibai et al. [4], Monico et al. [9] and Graham [12].

In addition, the literature supports our finding by describing preeclampsia as being a high inflammatory response of the mother against pregnancy [13]. The literature also describes that thrombocytopenia and increasing of thrombocyte volume are the most valuable criteria for designation of severity of preeclampsia [14,15]. In their study of 1869388 patients in Norway between 1967 and 1988, Per Magnus and Anne Eskild (2001), reported that they en-countered preeclampsia in 2.7% (51801 patients) [16].

Similar studies performed in other countries describe that preeclampsia has a systematically seasonal variation [16]. They indicate that preeclampsia can occur frequently in winter and rarely in summer. Similarly, in the literature, incidence of preeclampsia in autumn and in winter was 50.9% and in spring and in summer 9.1%. Accordingly, we get the hypothesis that the probability of preeclampsia is higher in a cold climate, increasing the vasoconstric-tion, which plays an important role in the pathogenesis of preeclampsia as it does in myocardial ischaemia [8].

In conclusion, platelet number and gestational week at hospital admission time are a predictor of the prognosis of the patient.


I would like to thank Dr. Hüseyin İvit, Obstetrician and Gynecologist, Chief Assistant of Department of Obstet-rics and Gynecology in Atatürk Research and Training Hospital, İzmir and Professor Dr. Atilla Köksal, Professor of Obstetrics and Gynecology, Chief of Department of Obstetrics and Gynecology in Atatürk Research and Training Hospital in Atatürk Research and Training Hos-pital, İzmir, for their help with my education during my Obstetrics & Gynecology rotation and the preparation of this manuscript.


WBC: White Blood Count
ALP: Alcaline phosphatase
LDH: Lactic dehydrogenase


  1. Branch DW, Porter TF. Hypertensive disorders of pregnancy, Scott JR, Sala PJD, Hammond CB, Spel-lacy WN, editors, in Danforth’s Obstetrics and Gynecology. Philadelphia USA: Lippincott Williams & Wilkins, 1999, 309-326.
  2. Pernoll ML. Hypertensive state of pregnancy, the preg-nancy at risk, section III, chapt.18, pp.373-380, in cur-rent British Journal Obstet & Gynecology, Diagnosis & Treatment, William C, Mabie, Baha M.Sibai (Editors), Lange, 1994.
  3. Conde-Agudelo A, Belizan JM. Risk factors for preeclampsia in a large cohort of Latin American and Carib-bean Women, Br J Obstet and Gynaecol, 2000, 107, 75, 82.
  4. Sibai BM, Mc Cubbin JH, Anderson GD, et al. Eclampsia: I. Observation from 67 cases. Obstet Gynecol 1981; 48: 609.
  5. Newmann MG, Robichoux AG, Stedman CM, Jaekle RK, Fontenat MT, Dotson T, Lewis DF. Perinatal Out-comes in Preeclampsia Complicated by Massive Proteinuria. Am J Obstet and Gynecol, 2003; 188: 1: 264-268.
  6. Goodlin RC, Cottoni DB, Haesslein HC. Severe oedema, proteinuria-hypertension gestosis. Am J Obstet and Gynecol 1978; 2: 595.
  7. Schiff E, Freidman SA, Kao L, Sibai BM. The Importa-nce of Urinary Protein Excretion During Conservative Management of Severe Preeclampsia. Am J Obstet and Gynecol 1996; 175; 5: 1313-1316.
  8. Yang R, Thomas GR, Bunting S et al. Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J Cardiovasc Pharmacol 1996; 27: 834-844.
  9. Longo M, Jain V, Vedernikov YP, Facchinetti F.,Saade G.R., Garfield R.E., Endothelium dependence and ges-tational inhibition of vascular tone by magnesium sulfate in rat aorta. Am J Obstet and Gynecol 2001; 184: 971-978.
  10. Adelber AM, Miller J, Doerzbacher M, Lambers D.S. Correlation of Quantitative Protein Measurement in 8-12 And 24 Hours Urine Samples for the Diagnosis of Preeclampsia. Am J Obstet and Gynecol 2001; 185: 4: 804-807.
  11. Wough J, Perry IJ, Halligan AWF, De Swiet M, Lambert PC, Penny JA, Taylor DJ. Birth weight and 24 hour ambulatory blood pressure in non proteinuric hypertensive pregnancy. Am J Obstet Gynecol 2000; 183: 633-637.
  12. Graham KM. Magnesium sulphate in eclampsia. Lancet 1998; 352: 67-68.
  13. Redman CWG, Sacks GP, Sargent IL. Preeclampsia an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180: 499-506.
  14. Rowland BL, Vermillian ST, Roudelbush WE. Elevated circulating concentration of platelet activating fac-tor in preeclampsia. Am J Obstet and Gynecol 2000; 183: 930-932.
  15. Ahmed Y, van Iddekinge B, Paul C, Sullivan HF, Elder MG. Retrospective analysis of platelet numbers and volumes in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol. March 1993; 100: 3: 216-220.
  16. Magnus P, Esklid A. Seasonal variation in the occurrence of preeclampsia. Br J Obstet and Gynaecol 2001; 108: 1116-1119.

Haluk Mergen

Esentepe Mh. Tuna Cd. Gür Sk
Salkım-3 Sitesi B Blok No:1/6
Nilüfer, Bursa, Turkey
GSM: +90-532-4419651
Phone: +90-224-2940209 (Work)
E-mail: haluk.mergen(at)

204 Biomedical Research Volume 21 Issue 2
Biomedical Research 2010; 21 (2): 204-207

Access free medical resources from Wiley-Blackwell now!

About Indmedica - Conditions of Usage - Advertise On Indmedica - Contact Us

Copyright © 2005 Indmedica